Ebola
-
Viral infections can be difficult to tackle due to their ability to develop resistance to drugs, and major viruses like Ebola and Zika pose a real threat to global health. Help might well be at hand though, with researchers developing a macromolecule that tackles viruses in three separate ways.
-
The sooner the Ebola virus is detected in blood samples, the better. Unfortunately, those samples currently have to be shipped off to labs for analysis. That could soon change, though, as a compact new device can identify Ebola in under half an hour.
-
Despite serving as a natural host for more than 100 different viruses, bats don't display any resulting signs of disease. Australian scientists are claiming to have now figured out why, in a revelation that moves us closer to safeguarding the human population from Ebola and other deadly diseases.
-
ScienceA new low-cost device could be used to diagnose diseases in remote regions, where limited health facilities make it difficult to deal with epidemics. The system can provide accurate diagnoses from tiny samples of blood, and has been successfully tested with Ebola.
-
There is a glimmer of hope in the fight against Ebola with the World Health Organization (WHO) announcing that in trials, a vaccine called VSV-EBOV has proven to be 100 percent effective in protecting individuals against the virus.
-
Researchers from MIT claim to have developed an easy-to-use blood test that can be applied in the field, allowing for the screening of multiple diseases. The test is said to provide results in around 10 minutes, and could be instrumental in stopping the epidemic spread of diseases such as Ebola.
-
To make moving and treating Ebola patients safer, Johns Hopkins University along with international health affiliate Jhpiego and other partners are developing a new anti-contamination suit for health care workers that is both cooler to wear and easier to remove.
-
Scientists have produced a single dose Ebola vaccine shown to provide primates with long-term protection from the deadly disease. The vaccine is administered through the nose and lungs, mitigating the associated risk of spreading the disease through infected needles.